For patients with suspected COVID-19 infection. The radip test requires no instruments and delivers results within 15 minutes, making it a valuable tool for large-scale testing in decentralized testing facilities.
Requires no instruments and delivers results within 15 minutes, making it a valuable tool for large-scale testing in decentralized testing facilities.
Accessible, portable and scalable option for testing for COVID-19.
May also be useful to support public health strategies such as source and contact tracing and large-scale testing of people with suspected active infection.
A rapid in vitro diagnostic test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swabs from individuals meeting the clinical and/or epidemiological criteria for COVID-19. The Panbio™ COVID-19 Ag Rapid Test Device is for professional use only and is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection. The product can be used in laboratories and in any other environment that meets the requirements specified in the instructions for use and local regulations.
The test provides preliminary test results. Negative results do not rule out infection with SARS-CoV-2 and cannot be used as the sole basis for treatment or other decision-making. Negative results should be combined with clinical observations, patient history and epidemiological information. The test is not intended to be used as a donor screening test for SARS-CoV-2.